Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasaprohyai extract versus loratadine for allergic rhinitis
TCTR20231025003Phase 3Completed
- Sponsor
- Thammasat University
- Start
- Oct 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of loratadine in allergic rhinitis (AR), sponsored by Thammasat University. Started Oct 2022; status: completed.
02
Drugs
loratadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20231025003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231025003.